352 related articles for article (PubMed ID: 17595511)
1. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection.
Javadov S; Karmazyn M
Cell Physiol Biochem; 2007; 20(1-4):1-22. PubMed ID: 17595511
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
4. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?
Javadov S; Jang S; Parodi-Rullán R; Khuchua Z; Kuznetsov AV
Cell Mol Life Sci; 2017 Aug; 74(15):2795-2813. PubMed ID: 28378042
[TBL] [Abstract][Full Text] [Related]
8. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
Lu N; Sun Y; Zheng X
Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole.
Di Lisa F; Bernardi P
Cardiovasc Res; 2006 May; 70(2):191-9. PubMed ID: 16497286
[TBL] [Abstract][Full Text] [Related]
10. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
11. The mitochondrial permeability transition pore as a target of cardioprotective signaling.
Baines CP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H903-4. PubMed ID: 17513492
[No Abstract] [Full Text] [Related]
12. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition.
Javadov S; Choi A; Rajapurohitam V; Zeidan A; Basnakian AG; Karmazyn M
Cardiovasc Res; 2008 Jan; 77(2):416-24. PubMed ID: 18006455
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of NAADP signalling on reperfusion protects the heart by preventing lethal calcium oscillations via two-pore channel 1 and opening of the mitochondrial permeability transition pore.
Davidson SM; Foote K; Kunuthur S; Gosain R; Tan N; Tyser R; Zhao YJ; Graeff R; Ganesan A; Duchen MR; Patel S; Yellon DM
Cardiovasc Res; 2015 Dec; 108(3):357-66. PubMed ID: 26395965
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
Sun Y; Zhang Y; Yan M; Wu Y; Zheng X
Biol Pharm Bull; 2009 Sep; 32(9):1545-51. PubMed ID: 19721230
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy.
Rees PS; Davidson SM; Harding SE; McGregor C; Elliot PM; Yellon DM; Hausenloy DJ
Cardiovasc Drugs Ther; 2013 Jun; 27(3):235-7. PubMed ID: 23380984
[No Abstract] [Full Text] [Related]
16. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
[TBL] [Abstract][Full Text] [Related]
17. Purine release: a protective signaling mechanism of the mitochondrial permeability transition pore in ischemia.
Nadtochiy SM; Nauduri D; Shimanskaya TV; Sagach VF; Brookes PS
Fiziol Zh (1994); 2008; 54(6):5-14. PubMed ID: 19227234
[TBL] [Abstract][Full Text] [Related]
18. Anesthetic cardioprotection in relation to mitochondria: basic science.
Mio Y; Uezono S; Kitahata H
Curr Pharm Des; 2014; 20(36):5673-80. PubMed ID: 24502577
[TBL] [Abstract][Full Text] [Related]
19. MCUb Induction Protects the Heart From Postischemic Remodeling.
Huo J; Lu S; Kwong JQ; Bround MJ; Grimes KM; Sargent MA; Brown ME; Davis ME; Bers DM; Molkentin JD
Circ Res; 2020 Jul; 127(3):379-390. PubMed ID: 32299299
[TBL] [Abstract][Full Text] [Related]
20. Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway.
Hadzimichalis NM; Baliga SS; Golfetti R; Jaques KM; Firestein BL; Merrill GF
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3348-55. PubMed ID: 17921323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
